Work

176 (PB164): IKS012, a novel ADC design with favorable efficacy and safety for treatment of Folate Receptor Alpha-positive cancers

Year: 2024

Type: article

Source: European Journal of Cancer

DOI: 10.1016/j.ejca.2024.114697

Authors: A. Lodge, S. Bousis, J. Stephenson, S. Robinson, W.A. Stanley, J. Mysliwy, J. Deckert, J. Thirlway, R.J. Lutz

Language: English

Topic: Monoclonal and Polyclonal Antibodies Research

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4403763403

FWCI:

Cites:

Cited by:

Related to: 10